Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:

EU Tissue Procurement Directive Adopted; HTP Draft Forthcoming

This article was originally published in The Gray Sheet

  • News

Executive Summary

The European human tissue product (HTP) market likely will be more navigable - and increasingly attractive to large firms - following the adoption of a pending EU tissue product directive

You may also be interested in...



Tissue Bank Regs Fall Under Increased Senate Govt. Affairs Panel Scrutiny

FDA is being asked to provide Senate Governmental Affairs Committee Chair Susan Collins (R-Maine) with all documentation pertaining to the agency's delayed tissue regulations by Sept. 12

EU Tissue Laws: TSE Directive Issued, Industry Awaits Additional HTP Rules

European Union member states must adopt and publish the European Commission's new directive on medical devices using tissues of animal origin by Jan. 1, 2004

Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker

Table

View full table

Tags:
UsernamePublicRestriction

Register

OM007016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By